Real life experience of first line anti-TNF in Crohn´s disease patients in Spain: do we have data to choose between infliximab and adalimumab?

Ignacio Marín-Jiménez  1     Guillermo Bastida  2     Ana Fores  3     Federico Argüelles-Arias  4     Ignacio Tagarro  5     Alonso Fernandez  5     Carmen Montoto Otero  5     Mariam Aguas  6     Rocio Ferreiro Iglesias  7     Olga Merino     Javier Santos Fernandez     Xavier Cortés     Francisco Mesonero Gismero     Manuel Barreiro de Acosta    
1 Hospital Gregorio Marañón,Madrid,Spain
2 Hospital La Fe,Valencia,Spain
3 Hospital General de Castelló,Castellón,Spain
4 HUV Macarena,Sevilla,Spain
5 Takeda Farmaceutica España,Madrid,Spain
6 La Fe Universitary and Politecnic Hospital,Valencia,Spain
7 Univer

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing